gold has been researched along with raltegravir potassium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bresee, J; Carter, CJ; Dahl, NP; Feldheim, DL; Garrido, C; Harris, TL; Lindsey, EA; Margolis, DM; Melander, C; Simpson, CA; Smith, CA; Whitehead, DC | 1 |
1 other study(ies) available for gold and raltegravir potassium
| Article | Year |
|---|---|
Gold nanoparticles to improve HIV drug delivery.
Topics: Animals; Anti-HIV Agents; Brain; Drug Carriers; Endothelial Cells; Female; Gold; HIV Core Protein p24; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Macrophages; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Raltegravir Potassium; Tissue Distribution; Virus Replication | 2015 |